PeptideDB

Tivanisiran (SYL1001) 1848224-71-4

Tivanisiran (SYL1001) 1848224-71-4

CAS No.: 1848224-71-4

Tivanisiran (SYL1001) is an siRNA used in dry eye disease study. Tivanisiran is used to silence TRPV1 mRNA.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Tivanisiran (SYL1001) is an siRNA used in dry eye disease study. Tivanisiran is used to silence TRPV1 mRNA.

Physicochemical Properties


CAS # 1848224-71-4
Appearance White to off-white solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Tizanisiran transfection in vitro has the ability to slash TRPV1 mRNA levels by 50–60%[1][2].
References

[1]. Development of tivanisiran, a topical siRNA designed to.

[2]. Tivanisiran, a novel siRNA for the treatment of dry eye disease. Expert Opin Investig Drugs. 2018 Apr;27(4):421-426.


Solubility Data


Solubility (In Vitro) H2O: 100 mg/mL
Solubility (In Vivo) Solubility in Formulation 1: 25 mg/mL (Infinity mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)